111, Inc. (YI) Financial Statements
111, Inc. (YI) reported trailing twelve-month revenue of $10.5B (down 25.7% year on year) and net income of -$22.5M as of 2026-06-30, according to EquiReason's reading of its SEC filings. Free cash flow over the same period: $114.7M.
Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason
YI111, Inc.Follow YI — free
—
Price chart with a free account
- Market cap
- 25.1M
- P/E TTM
- —
- Dividend yield
- —
- 52-week
- —
- Next earnings
- 15 Dec, in 52 days
Fiscal-year columns end in the month shown. The current fiscal year appears once its annual report is filed; until then TTM = the last four reported quarters, to Jun 26.
| Line | FY2018 Dec 18 | FY2019 Dec 19 | FY2020 Dec 20 | FY2021 Dec 21 | FY2022 Dec 22 | FY2023 Dec 23 | FY2024 Dec 24 | FY2025 Dec 25 | TTM Jun 26 | Trend |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 1.79 | 3.95 | 8.20 | 12.43 | 13.52 | 14.95 | 14.40 | 12.56 | 10.50 | |
| Gross profit | 0.10 | 0.17 | 0.37 | 0.62 | 0.84 | 0.85 | 0.83 | 0.72 | — | |
| Operating income | -0.40 | -0.49 | -0.47 | -0.64 | -0.37 | -0.35 | 0.00 | -0.00 | — | |
| Pre-tax income | -0.38 | -0.50 | -0.47 | -0.62 | -0.38 | -0.35 | -0.02 | -0.02 | — | |
| Income tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | — | |
| Net income | -0.38 | -0.50 | -0.47 | -0.62 | -0.38 | -0.35 | -0.02 | -0.02 | — | |
| Diluted EPS ($) | -0.56 | -0.44 | -0.42 | -0.63 | -2.50 | -2.33 | -0.38 | -0.05 | — | |
| Diluted shares (bn) | — | — | — | 0.166 | 0.167 | 0.169 | 0.172 | 0.174 | — |
USD billions · SEC XBRL
111, Inc. — questions
- What is 111, Inc.'s revenue?
- $10.5B over the twelve months to 2026-06-30, down 25.7% year on year, from its 10-Q and 10-K filings.
- What is 111, Inc.'s net income?
- -$22.5M over the twelve months to 2026-06-30.
- What is 111, Inc.'s free cash flow?
- $114.7M over the twelve months to 2026-06-30.
Every figure on this page comes from 111, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.